Change in Preferred Drug List Status for the Antiemetic-Antivertigo Agents, Drug Class, Effective Jan. 15, 2025
HHSC removed the non-preferred status from the generic scopolamine patch products on the preferred drug list (PDL) effective Jan. 15, 2025, in response to the distribution delays for patch products with the preferred brand name Transderm-Scopolamine. Providers can prescribe the generic scopolamine patches without requiring a PDL prior authorization, allowing clients to continue accessing necessary medication. The following table lists the generic scopolamine products with their National Drug Codes (NDCs).
NDC | Drug Name |
---|---|
00378647044 | SCOPOLAMINE 1 MG/3 DAY PATCH |
00378647097 | SCOPOLAMINE 1 MG/3 DAY PATCH |
00378647099 | SCOPOLAMINE 1 MG/3 DAY PATCH |
00591225804 | SCOPOLAMINE 1 MG/3 DAY PATCH |
00591225823 | SCOPOLAMINE 1 MG/3 DAY PATCH |
00591225879 | SCOPOLAMINE 1 MG/3 DAY PATCH |
45802058046 | SCOPOLAMINE 1 MG/3 DAY PATCH |
45802058062 | SCOPOLAMINE 1 MG/3 DAY PATCH |
45802058084 | SCOPOLAMINE 1 MG/3 DAY PATCH |
50742050504 | SCOPOLAMINE 1 MG/3 DAY PATCH |
50742050510 | SCOPOLAMINE 1 MG/3 DAY PATCH |
50742050524 | SCOPOLAMINE 1 MG/3 DAY PATCH |